Carregant...
Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease
Three long-acting muscarinic antagonists (LAMAs) are now available in Europe, providing clinicians and patients with a choice of interventions, which is important in COPD, which is clinically a heterogeneous disease. The first LAMA, tiotropium, has been widely used over the last decade as a once-dai...
Guardat en:
| Publicat a: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381904/ https://ncbi.nlm.nih.gov/pubmed/25848244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S76520 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|